• TRM (USD/COP)COP 3,235.59 +1.65% +COP 52.60Colombia's official exchange rate (Financial Superintendence), valid Nov 4 to Nov 4
  • EuroCOP 3,617.08 +1.72% +COP 61.02Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
  • Mexican pesoCOP 173.98 +3.35% +COP 5.64Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote

Labiana lifts EBITDA 10.2% and posts 41.26 million euros in first-half revenue

FinanceInternational3tres3.com35 s readAI summary
Image: 3tres3.com

Labiana Health, a Spanish pharmaceutical group listed on BME Growth, reported revenue of 41.26 million euros in the first half of 2026, up 5.2%, with adjusted EBITDA of 8.20 million (+10.2%) and adjusted EBIT of 6.19 million (+14.2%). Animal Health grew 9.6% and accounted for 50.3% of sales. Net income was 0.93 million, after 3.5 million in extraordinary financial expenses from cancelling the previous financing with Miralta/Blantyre.

In 35 seconds

  • Revenue of 41.26 million euros, up 5.2%, and adjusted EBITDA of 8.20 million (+10.2%)
  • Animal Health grew 9.6% to 20.77 million and represented 50.3% of consolidated revenue
  • Net income fell to 0.93 million due to 3.5 million in extraordinary financial expenses tied to cancelling the previous financing
Read the full story at 3tres3.com

IASummary generated by artificial intelligence from a story by 3tres3.com. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading